Title: STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial Background/Purpose: STEMI guidelines recommend pharmaco-invasive treatment if timely primary percutaneous coronary intervention (PCI) is unavailable. In the STREAM-1 study (Strategic Reperfusion Early After Myocardial Infarction), a pharmaco-invasive strategy resulted in similar rates of death, shock, heart failure, […]
The post Episode 109. STREAM-2 Study Journal Club with Nick Servati and Alex Cruz Pabon appeared first on The Pharm So Hard Podcast.